No abstract

As palm oil has been qualified as atherogen, we have studied the impact of its consumption on changes of lipid and lipoprotein profiles of young Ivorian healthy subjects living in rural areas. It is a descriptive cross-sectional analytical study of about 120 Ivorian subjects aged 18 to 30 years, including 65 regular consumers of palm oil and 55 subjects consuming that oil periodically as control subjects. Serum concentrations of triglycerides, total cholesterol, HDL, LDL cholesterols and lipoprotein (a) were measured by enzyme conventional methods. The TC serum varied not significantly in both subjects' groups as the triglycerides and HDL-C did. In addition, 58.46% of palm oil consumers had hypoLDLemia. The serum concentration of lipoprotein (a) was not significantly elevated (p> 0.05) with consumers compared to controls: 33.85% versus 29.09%, p = 0.55. The percentage of subjects with normal serum concentrations is higher in all the studied parameters, with both that is the consumers and the controls, except LDL cholesterol, of which the percentage of subjects with a lower value is the highest (58.46% for consumers and 52.73% for controls). This study has shown that the consumption of palm oil did not alter the lipid and lipoprotein profile of the consumer, on the contrary, this consumption revealed a decrease in cholesterol levels with these subjects.

Palm oil is often not recommended to overweight patients, on the pretext that it provides saturated fat and cardiovascular diseases. This work studied variations in lipid and lipoprotein parameters in overweight consumers versus nonconsumers of palm oil who came for visits at the nutrition department of the National Institute of Public Health of Adjamé in Abidjan, Côte d'Ivoire. We included 328 overweight subjects, including 227 palm oil consumers and 101 non-consumers, in a three-month descriptive and analytical cross-sectional, prospective study. The lipid parameters analysed by enzymatic technique were total cholesterol, triglycerides, HDL and LDL cholesterol. The atherogenicity index was also determined. The comparison of proportions was made by the chi square-test (5%). Moderate obesity accounted for 41.6%, overweight 31.2%. Among the patients, 89% consumed palm oil, and 11% did not. In palm oil consumers, 64.2% had normal cholesterol, while 16.1% had hypercholesterolemia. Among non-consumers, 75% had normal cholesterol compared to 25% hypercholesterolemia. The difference was not significant in both groups. Serum triglycerides, HDL, LDL cholesterols, and atherogenicity index varied in the same range as total cholesterol, with no significant difference observable, whatever the form of palm oil consumed. The non-significative variation of lipid and lipoprotein parameters in palm oil consumers and nonconsumers, showed that normal consumption of palm oil has no significant effect on weight gain. This consumption is beneficial because of the presence of antioxidants in palm oil, which gives it its health and nutritional benefits.

The aim of this study was to determine the correlation between glycated hemoglobin and blood sugar levels in diabetic subjects carried out in Abidjan. This cross-sectional study included 100 patients with diabetes monitored, for three months, for whom glycated blood glucose and hemoglobin were performed, this after informed consent of the patients. Pearson and Spearman correlation tests were used, at the 5% threshold. The patients with normal HbA1C and normal blood glucose accounted for 55.34 and 32%, respectively. A sedentary lifestyle and body mass index > 25 kg/m² were associated with a significant increase in the risk of increased blood glucose and HbA1C. The presence of a complication was associated with a 3.06-fold higher risk of high glycated hemoglobin (p= 0.0073), while blood glucose was not significantly associated with the onset of complications. Glycated hemoglobin was significantly correlated with blood glucose with a correlation coefficient of 0.4412 (p 0.0001). In multivariate analysis, hyperglycemia was significantly associated with alcohol consumption and noncompliance with antidiabetic treatment. Poor compliance was significantly associated with increased glycated hemoglobin (>7%) and tobacco consumption. The glycated hemoglobin was highly correlated with blood sugar, and was found to be a better predictor of diabetes complications than glycemia.

To study the changes in lipid and lipoprotein parameters in a group of hypertensive patients, consuming palm oil or not, at the Abidjan Heart Institute. Methods: We recruited 196 hypertensive patients, which were divided into two group's consumers and non-consumers of palm oil. We analyzed total cholesterol, triglycerides, HDL cholesterol, LDL cholesterol and atherogenic index. Results: Participants' mean age was 57.13 years. Among palm oil consumers, 56.7% had normal cholesterol levels, while 30.8% had high cholesterol levels. In non-palm oil users, cholesterolemia was normal in 56.5% and elevated in 27.2%. Similarly, serum values of triglycerides, HDL cholesterol, LDL cholesterol and atherogenic index, also showed no significant difference between palm oil consumers and non-consumers. Conclusion:The consumption of palm oil does not significantly influence the lipid and lipoprotein parameters and therefore, has no effect on increasing blood pressure.